Also trades as: SHWZ.NE (NEO) · $vol 0M
SHWZ OTC
Medicine Man Technologies, Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: -90.0%
1Y: -99.0%
3Y: -100.0%
5Y: -100.0%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
$12M
+7.1% ▲
5Y CAGR: +56.8%
Capital Expenditures
$11M
+28.3% ▲
5Y CAGR: +250.6%
Free Cash Flow
$2M
+146.4% ▲
5Y CAGR: +4.6%
Dividends Paid
$0
+0.0% ▲
Buybacks
$109K
+0.0% ▲
Net Change in Cash
-$20M
+70.8% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$17M | -$19M | $15M | -$18M | -$35M |
| Depreciation & Amort. | $62K | $477K | $9M | $11M | $21M |
| Stock-Based Comp. | $7M | $8M | $5M | $812K | $4M |
| Change in Working Capital | -$3M | $3M | -$4M | $12M | $15M |
| Other Non-Cash Items | $6M | -$3M | $33M | $9M | $10M |
| Operating Cash Flow | -$8M | -$10M | $57M | $11M | $12M |
| — Investing Activities — | |||||
| Capital Expenditures | -$200K | -$768K | -$6M | -$15M | -$8M |
| Acquisitions (Net) | $0 | -$33M | -$76M | -$62M | -$16M |
| Investment Purchases | $0 | $0 | $0 | -$2M | $0 |
| Investment Sales | $0 | $0 | $0 | $2M | $0 |
| Other Investing | -$917K | $827K | $182K | -$2M | -$3M |
| Investing Cash Flow | -$1M | -$33M | -$81M | -$79M | -$26M |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | $19M | $128M | -$134K | -$5M |
| Stock Repurchased | $0 | $0 | $0 | $0 | -$109K |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $603K | $0 | -$49M | $467K | $0 |
| Financing Cash Flow | $20M | $32M | $129M | $844K | -$5M |
| Net Change in Cash | $12M | -$11M | $105M | -$67M | -$20M |
| Cash End of Period | $12M | $1M | $106M | $39M | $19M |
| Free Cash Flow | -$8M | -$11M | $52M | -$3M | $2M |